SOLV logo

Solventum (SOLV)

Profile

Full Name

Solventum Corporation

Ticker Symbol

SOLV

Exchange

NYSE

Sector

Healthcare

Industry

Medical Instruments & Supplies

Country

United States

IPO

April 1, 2024

Indexes

S&P 500

Website

http://www.solventum.com

Employees

22000

Key Details

Price

$65.93(-2.76%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$8.25B(+0.70% YoY)

Annual EPS

$2.76(-64.57% YoY)

PE ratio

23.97

Next earnings date

May 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$65.93
SOLV price is $65.93

30-Day Relative Volume

0.63
SOLV 30-day relative volume is 0.63

Price Performance

Price Most recent change

-2.76%
SOLV price was down -2.76% on Apr 15, 2025

Price YTD change

-0.2%
SOLV price is down -0.2% since January 1st

Price 1-year change

+6.87%
SOLV price is up +6.87% year-on-year

Price 3-year change

-
SOLV price 3-year change is unknown

Price Range

Price All-time high

$85.92
SOLV price is currently -23.27% below its historical high of $85.92

Price 3-year low

$47.16
SOLV price is currently +39.80% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$11.41B
SOLV market capitalization is $11.41 billion

Market cap 3-year change

-
SOLV market capitalization 3-year change is unknown

Market cap All-time high

$14.62B
SOLV market capitalization is currently -21.98% below its historical high of $14.62 billion

Market cap sector rank

93.42%
SOLV market capitalization is higher than 93.42% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.16%
SOLV shares outstanding is up +0.16% year-on-year

Shares Outstanding 3-Year Change

-
SOLV shares outstanding 3-year change is unknown

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.79
SOLV beta is 0.79

200-day SMA

$68.01
SOLV price is currently -3.06% below its 200-day simple moving average

50-day SMA

$74.24
SOLV price is currently -11.20% below its 50-day simple moving average

RSI

39.47
SOLV 14-day relative strength index is 39.47

Volume

0.63
SOLV 30-day relative volume is 0.63

ATR

$3.33
SOLV average true range is $3.33

10-day Historical Volatility

78.08%
SOLV 10-day historical volatility is 78.08%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$8.25B
SOLV annual revenue is $8.25 billion

Revenue Analysts estimate

$8.27B
SOLV annual revenue is currently -0.24% lower than the consensus analysts' forecast

Revenue 1-year change

+0.7%
SOLV annual revenue is up +0.7% year-on-year

Revenue Sector rank

93.39%
SOLV annual revenue is higher than 93.39% of companies in Healthcare sector

EPS

EPS

$2.76
SOLV annual earnings per share is $2.76

EPS Analysts estimate

$5.54
SOLV annual earnings per share is currently -50.20% lower than the consensus analysts' forecast

EPS 1-year change

-64.57%
SOLV annual earnings per share is down -64.57% year-on-year

EPS Sector rank

93.63%
SOLV annual earnings per share is higher than 93.63% of companies in Healthcare sector

Profit

Gross profit

$4.59B
SOLV annual gross profit is $4.59 billion

Gross margin

55.65%
SOLV annual gross profit margin is 55.65%

Operating profit

$1.04B
SOLV annual operating income is $1.04 billion

Operating margin

12.55%
SOLV annual operating profit margin is 12.55%

Net income

$479.00M
SOLV annual net profit is $479.00 million

Net margin

5.80%
SOLV annual net profit margin is 5.80%

Expenses

Total expenses

$7.22B
SOLV annual total expenses is $7.22 billion

Operating expenses

$3.56B
SOLV annual total operating expenses is $3.56 billion

Cost of goods sold

$3.66B
SOLV annual cost of goods sold is $3.66 billion

Selling, general & administrative expenses

$2.78B
SOLV annual SGA is $2.78 billion

Depreciation and amortization

$555.00M
SOLV annual depreciation & amortization is $555.00 million

Interest expense

$367.00M
SOLV annual interest expense is $367.00 million

Income tax

$127.00M
SOLV annual income tax is $127.00 million

EBIT & EBITDA

EBIT

$972.00M
SOLV annual earnings before interest & taxes is $972.00 million

EBITDA

$1.53B
SOLV annual EBITDA is $1.53 billion

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$14.46B
SOLV annual total assets is $14.46 billion

Non current assets

$11.21B
SOLV annual long term assets is $11.21 billion

Current assets

$3.25B
SOLV annual total current assets is $3.25 billion

Cash and cash equivalents

$762.00M
SOLV annual cash & cash equivalents is $762.00 million

Accounts receivable

$1.04B
SOLV annual accounts receivable is $1.04 billion

Inventory

$965.00M
SOLV annual inventory is $965.00 million

Liabilities

Total liabilities

$11.50B
SOLV annual total liabilities is $11.50 billion

Long term liabilities

$8.79B
SOLV annual total long term liabilities is $8.79 billion

Current liabilities

$2.70B
SOLV annual total current liabilities is $2.70 billion

Accounts payable

$618.00M
SOLV annual accounts payable is $618.00 million

Debt

Total debt

$8.01B
SOLV annual total debt is $8.01 billion

Total debt 1-year change

-3.53%
SOLV annual total debt is down -3.53% year-on-year

Long term debt

$7.81B
SOLV annual long term debt is $7.81 billion

Short term debt

$200.00M
SOLV annual short term debt is $200.00 million

Equity & Capital

Shareholders equity

$2.96B
SOLV annual stockholders equity is $2.96 billion

Book value

$2.96B
SOLV annual book value is $2.96 billion

Retained earnings

$242.00M
SOLV annual retained earnings is $242.00 million

Working capital

$546.00M
SOLV annual working capital is $546.00 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$1.19B
SOLV annual cash flow from operations is $1.19 billion

Cash from operations 1-year change

-38.12%
SOLV annual cash flow from operations is down -38.12% year-on-year

Cash from investing

-$380.00M
SOLV annual cash flow from investing activities is -$380.00 million

Cash from investing 1-year change

-65.22%
SOLV annual cash flow from investing activities is down -65.22% year-on-year

Cash from financing

-$240.00M
SOLV annual cash flow from financing activities is -$240.00 million

Cash from financing 1-year change

+84.54%
SOLV annual cash flow from financing activities is up +84.54% year-on-year

CAPEX

CAPEX

$380.00M
SOLV annual capital expenditures is $380.00 million

CAPEX 1-year change

+31.03%
SOLV annual capital expenditures is up +31.03% year-on-year

Free Cash Flow

Free cash flow

$805.00M
SOLV annual free cash flow is $805.00 million

Free cash flow 1-year change

-50.46%
SOLV annual free cash flow is down -50.46% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

55.65%
SOLV annual gross profit margin is 55.65%

Operating margin

12.55%
SOLV annual operating profit margin is 12.55%

Net margin

5.80%
SOLV annual net profit margin is 5.80%

ROA & ROE

ROA

3.37%
SOLV annual return on assets is 3.37%

ROE

6.55%
SOLV annual return on equity is 6.55%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

23.97
SOLV price to earnings ratio is 23.97

PE ratio Sector rank

47.55%
SOLV price to earnings ratio is higher than 47.55% of companies in Healthcare sector

PB Ratio

PB ratio

3.85
SOLV price to book ratio is 3.85

PB ratio Sector rank

78.19%
SOLV price to book ratio is higher than 78.19% of companies in Healthcare sector

PS Ratio

PS ratio

1.38
SOLV price to sales ratio is 1.38

PS ratio Sector rank

33.85%
SOLV price to sales ratio is higher than 33.85% of companies in Healthcare sector

Enterprise value

Enterprise value

$18.65B
SOLV enterprise value is $18.65 billion

Enterprise value Sector rank

94.71%
SOLV enterprise value is higher than 94.71% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

12.22
SOLV EV/EBITDA is 12.22

EV/EBITDA Sector rank

85.48%
SOLV EV/EBITDA is higher than 85.48% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.20
SOLV annual current ratio is 1.20

Quick ratio

0.84
SOLV annual quick ratio is 0.84

Leverage

Debt to equity

2.71
SOLV annual debt to equity ratio is 2.71

Interest coverage ratio

2.65
SOLV annual interest coverage ratio is 2.65

Risk & Stability

Piotroski F-Score

-
SOLV piotroski f-score value is unknown

Altman Z-Score

1.46
SOLV altman z-score is 1.46

Analyst ratings

Recent major analysts updates

Mar 5, 25 Morgan Stanley
Equal-Weight
Mar 3, 25 Mizuho
Neutral
Mar 3, 25 Goldman Sachs
Sell
Feb 28, 25 Wells Fargo
Equal-Weight
Feb 28, 25 Piper Sandler
Neutral
Feb 26, 25 B of A Securities
Neutral
Dec 4, 24 Mizuho
Neutral
Nov 11, 24 Morgan Stanley
Equal-Weight
Nov 8, 24 Piper Sandler
Neutral
Oct 8, 24 Stifel
Buy

Institutional Ownership

Similar stocks

UHS logo
Universal Health Services (UHS)
SNN logo
Smith & Nephew (SNN)
BMRN logo
BioMarin Pharmaceutical (BMRN)
RVTY logo
Revvity (RVTY)
INCY logo
Incyte (INCY)
THC logo
Tenet Healthcare (THC)
DVA logo
DaVita (DVA)
RDY logo
Dr Reddys Laboratories Limited (RDY)
ICLR logo
ICON Public Limited (ICLR)
  • What is the ticker symbol for Solventum?
  • Does Solventum pay dividends?
  • What sector is Solventum in?
  • What industry is Solventum in?
  • What country is Solventum based in?
  • When did Solventum go public?
  • Is Solventum in the S&P 500?
  • Is Solventum in the NASDAQ 100?
  • Is Solventum in the Dow Jones?
  • When was Solventum's last earnings report?
  • When does Solventum report earnings?
  • Should I buy Solventum stock now?

What is the ticker symbol for Solventum?

The ticker symbol for Solventum is NYSE:SOLV

Does Solventum pay dividends?

No, Solventum does not pay dividends

What sector is Solventum in?

Solventum is in the Healthcare sector

What industry is Solventum in?

Solventum is in the Medical Instruments & Supplies industry

What country is Solventum based in?

Solventum is headquartered in United States

When did Solventum go public?

Solventum's initial public offering (IPO) was on April 1, 2024

Is Solventum in the S&P 500?

Yes, Solventum is included in the S&P 500 index

Is Solventum in the NASDAQ 100?

No, Solventum is not included in the NASDAQ 100 index

Is Solventum in the Dow Jones?

No, Solventum is not included in the Dow Jones index

When was Solventum's last earnings report?

Solventum's most recent earnings report was on Feb 27, 2025

When does Solventum report earnings?

The next expected earnings date for Solventum is May 9, 2025

Should I buy Solventum stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page